Secor Capital Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Secor Capital Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-296,278	Closed	-$1.38M	–	620
2017 Q1	$1.38M	Buy	296,278 +195,638	+194%	+$1.13M	0.15%	198
2016 Q4	$613K	Buy	+100,640	New	+$526K	0.07%	311
2016 Q3	–	Sell	-145,719	Closed	-$553K	–	730
2016 Q2	$553K	Buy	+145,719	New	+$494K	0.07%	374
2014 Q1	–	Sell	-40,894	Closed	-$227K	–	429
2013 Q4	$227K	Buy	+40,894	New	+$176K	0.09%	289

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Secor Capital Advisors's SGYP Position: Q2 2017 in Review

Secor Capital Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017, closing a stake of 296,278 shares — an estimated $1.38M sold.

Secor Capital Advisors first reported a position in SGYP in Q4 2013 and held it in 4 quarters. The position peaked at $1.38M in Q1 2017. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

Secor Capital Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2017 after selling out during the quarter.
Secor Capital Advisors sold 296,278 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2017, an estimated $1.38M.
Secor Capital Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2013 and held it in 4 quarters.
Secor Capital Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.38M in Q1 2017.
146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on Secor Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.